iWalk raises $17m in Series D financing
iWalk Inc., a Bedford company that uses innovations in bionics to help people with lower-limb loss gain more mobility, said Thursday that it has closed a private Series D equity financing round of $17 million.
The financing was led by new investor Gilde Healthcare Partners. Existing investors, including WFD Ventures, General Catalyst Partners, and Sigma Partners, also participated in the round, the company said in a press release.
Geoff Pardo, partner at Gilde Healthcare Partners, has joined the iWalk’s board of directors.
One iWalk product is the BiOM Ankle System, which emulates an individual’s calf muscles and Achilles tendon function to provide powered plantar flexion; that helps people with limb loss move with a natural gait by using the same metabolic energy as a non-amputee, iWalk said.
The company was founded in 2006 by Dr. Hugh Herr, director of the Biomechatronics Group at the MIT Media Lab.